Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse CancersAaron M. Goodman, Razelle Kurzrock, Shumei Kato et al.|Molecular Cancer Therapeutics|2017Cited by 2.4k
PD-L1 Expression as a Predictive Biomarker in Cancer ImmunotherapySandip Pravin Patel, Razelle Kurzrock|Molecular Cancer Therapeutics|2015Cited by 2.3k
Epstein-Barr Virus and CancerMatthew P. Thompson, Razelle Kurzrock|Clinical Cancer Research|2004Cited by 795
Review of precision cancer medicine: Evolution of the treatment paradigmApostolia M. Tsimberidou, Razelle Kurzrock, Elena Fountzilas et al.|Cancer Treatment Reviews|2020Cited by 747
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT studyJason K. Sicklick, Razelle Kurzrock|Nature Medicine|2019Cited by 710